Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Associative Learning01:27

Associative Learning

Associative learning is a fundamental concept in behavioral psychology, wherein a connection is established between two stimuli or events, leading to a learned response. This process is critical in understanding how behaviors are acquired and modified. Conditioning, the mechanism through which associations are formed, can be divided into two main types: classical conditioning and operant conditioning, each elucidating different aspects of associative learning.
Classical conditioning, also known...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.

International urology and nephrology·2014
Same author

Simple whole-cell biodetection and bioremediation of heavy metals based on an engineered lead-specific operon.

Environmental science & technology·2014
Same author

The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial-mesenchymal transition induced by hypoxia and TGF-β1.

European journal of pharmacology·2014
Same author

The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology.

Journal of ethnopharmacology·2014
Same author

Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.

Arteriosclerosis, thrombosis, and vascular biology·2014
Same author

Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

International journal of cardiology·2014

Related Experiment Video

Updated: Jul 14, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

TF-JointMAE: a self-supervised multi-representation EEG learning framework for Alzheimer's disease spectrum

Min Zuo1,2, Hong Zhu1, Zhenqiao Liu1

  • 1National Engineering Research Center for Agri-Product Quality Traceability, Beijing Technology and Business University, No.11 and No.33 Fucheng Road, Haidian District, Beijing, 100048 China.

Cognitive Neurodynamics
|July 13, 2026
PubMed
Summary

A new self-supervised learning framework, TF-JointMAE, enhances Alzheimer's disease (AD) detection using electroencephalography (EEG). It improves classification accuracy for early cognitive decline stages like mild cognitive impairment (MCI).

Keywords:
Alzheimer’s diseaseElectroencephalographyMasked autoencoderMild cognitive impairmentSelf-supervised learningSubjective cognitive decline

Related Experiment Videos

Last Updated: Jul 14, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Artificial Intelligence

Background:

  • Accurate identification of Alzheimer's disease (AD) and its early stages (subjective cognitive decline and mild cognitive impairment) is critical for effective intervention.
  • Electroencephalography (EEG) is a valuable, non-invasive tool for AD assessment, but its inherent complexities like non-stationarity and noise pose classification challenges.

Purpose of the Study:

  • To develop a robust self-supervised learning framework, TF-JointMAE (Temporal-Frequency Joint Masked Autoencoder), for improved classification of the AD spectrum using EEG.
  • To enhance EEG representation learning by jointly modeling temporal and time-frequency data and incorporating age as a physiological prior.

Main Methods:

  • Proposed TF-JointMAE framework utilizing self-supervised masked autoencoder pre-training on diverse public EEG datasets.
  • Jointly modeled temporal and time-frequency EEG representations, integrating age information within a unified embedding space.
  • Evaluated model performance on the CAUEEG and olfactory EEG datasets for Normal, Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), and Dementia classification.

Main Results:

  • TF-JointMAE achieved high test accuracies: 77.97% on the CAUEEG dataset and 96.43% on the olfactory EEG dataset.
  • The model demonstrated enhanced discriminative stability, particularly for the Mild Cognitive Impairment (MCI) category.
  • Occlusion-sensitivity analysis indicated that TF-JointMAE selectively utilizes specific EEG channels and time-frequency regions relevant to cognitive states.

Conclusions:

  • TF-JointMAE significantly improves the robustness and accuracy of EEG-based classification for the Alzheimer's disease spectrum.
  • The framework offers potential as an auxiliary tool for clinical decision-making in early AD detection and management.
  • The study provides reproducible results with publicly available source code, promoting further research in AI-driven neurological diagnostics.